Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.As of 26 May 2026, CORAL LABORATORIES LTD. share price is ₹496.00. The stock opened at ₹470.00, compared to its previous close of ₹465.70. During today's trading session, CORAL LABORATORIES LTD. share price moved in the range of ₹465.00 to ₹516.30, with an average price of ₹490.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹465.00 and a high of ₹516.30.
The market capitalization of CORAL LABORATORIES LTD. is ₹166 Crs, with a P/E ratio of 11.9 and a dividend yield of 0.00%.